Skip to main content
ABUS logo

ABUS · Arbutus Biopharma Corp

Track ABUS — free
$4.67 +0.09 (+1.97%) At close · Aug 14
Market Cap
$923.95M
Shares
197.85M

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Program Authorized
$230,000,000
as of 2026-07-16 · from 8-K (reviewed)
Program Announced Authorized Remaining Runs Through
2026-07-16 $230,000,000
Key facts CIK 1447028 CUSIP 03879J100 13F (30d) 173 filings 171 filers Visit website